検索
Can Fite Biopharma Ltd
CANFウォッチリストに追加
4.700USD
+1.730+58.25%
終値 07/01, 16:00（ET）15分遅れの株価
41.02K時価総額
損失額直近12ヶ月PER
詳細情報 Can Fite Biopharma Ltd 企業名
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Can Fite Biopharma Ltdの企業情報
企業コードCANF
会社名Can Fite Biopharma Ltd
上場日Sep 22, 2005
最高経営責任者「CEO」Fishman (Pnina)
従業員数5
証券種類Depository Receipt
決算期末Sep 22
本社所在地10 Bareket Street, Kiryat Matalon
都市PETAH TIKVA
証券取引所NASDAQ OMX – NASDAQ Basic Amex
国Israel
郵便番号49170
電話番号97239241114
ウェブサイトhttps://www.canfite.com/
企業コードCANF
上場日Sep 22, 2005
最高経営責任者「CEO」Fishman (Pnina)
Can Fite Biopharma Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
よくある質問
Can Fite Biopharma Ltdの上位5名の株主は誰ですか？
Can Fite Biopharma Ltdの上位5名の株主は以下のとおりです。Dr. Sari Fishman, Ph.D.
Can Fite Biopharma Ltd（CANF）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Can Fite Biopharma Ltdの株式を保有している機関は28社あり、保有株式の総市場価値は約32.13Kで、全体の1.50%を占めています。2025Q4と比較して、機関の持ち株は-81636.00増加しています。